CJC-1295 vs Tesamorelin for weight loss
Short answer: For weight loss, more users report improvement with CJC-1295 — 100% of 23 reports, versus 95% of 82 for Tesamorelin.
CJC-1295 has 0 meta-analyses and 1 randomized trials on PubMed; Tesamorelin has 3 and 21.
Based on 354 reports about CJC-1295 and 265 about Tesamorelin. Not medical advice.
| CJC-1295 Peptide | Tesamorelin Peptide | |
|---|---|---|
| Users say it helped | 57%helped131 reports · high confidence | 58%helped119 reports · high confidence |
| Verdict | Mixed | Mixed |
| Research | CResearch: Limited | AResearch: Strong |
| Meta-analyses / RCTs | 0 / 1 | 3 / 21 |
| Mainly used for | ||
| Weight loss % reporting improvement | 100% (23) | 95% (82) |
| Sleep % reporting improvement | 80% (44) | 70% (20) |
| Performance % reporting improvement | 96% (23) | 88% (25) |
| Recovery % reporting improvement | 97% (31) | 100% (10) |
| Hormones % reporting improvement | 79% (24) | 100% (4) |
| Common side effects | flushing, allergic reaction, itching, increased appetite | water retention, allergic reaction, anaphylaxis, swelling |
| Typical dose reported | Not listed | Not listed |
CJC-1295Full CJC-1295 profile →
What a user said
“Within a few weeks on cjc I noticed that I was more full, leaner, and sleep/recover was off the charts. My skin is crazy bright as well.”
TesamorelinFull Tesamorelin profile →
Latest review conclusion
However, limited data on long-term safety, optimal dosing strategies, and durability of treatment effects warrant caution. Future research should evaluate extended treatment duration, dose-response relationships, and patient-reported outcomes to establish comprehensive clinical utility.
J Int Assoc Provid AIDS Care, 2026 ↗What a user said
“I also added Tesamorelin 2 months in due to the harder time sleeping on Retatrutide and wanting to accelerate the burn of my visceral fats (2mg 5x a week). Worked like magic for me.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate